Department of urology

Research

Basic Research

The Department of Urology maintains a basic research laboratory focused on understanding the pathophysiology underlying of diseases affecting the lower urinary tract, particularly the bladder. The laboratory's web site can be found here.

Clinical Research

The Department of Urology participates in a variety of medical studies. An interdisciplinary team of physicians, PhD's, medical students, nurses, and other highly-qualified professionals collaborate on the following projects. In fact, we are an active member of the Southwest Oncology Group, and participate in a variety of local, national, and international research trials. Currently, the urology department have studies ongoing funded by NIH, NIDDK as well as VA Merit Award Funding, and VA Cooperative Studies Program Funding. We have a team of three research coordinators and collaborate to share resources between departments within our hospital.

Our department has been fortunate to work with the following organizations:

  • Alza Corporation
  • Astra Zeneca
  • Barr Laboratories
  • Department of Defense
  • Eli Lilly
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Pfizer
  • Sanofi - Avent S
  • Schering Plough
  • TAP
  • Ferring
  • Medivation
  • Imclone
  • Watson

Examples of projects include various drug therapies and quality-of-life assessments. Current research involves the following diagnoses:

  • bladder cancer
  • benign prostatic hyperplasia
  • prostate cancer
  • overactive bladder
  • erectile dysfunction
  • acute urinary retention
  • pediatric overactive bladder
  • complicated urinary tract infections
  • stress incontinence
  • interstitial cystitis


    If you would like more information on any of our clinical trials, please call our research coordinator at (843
    ) 876-0630.  We are committed to discovering, understanding, and healing.